Nachum Shamir has bought stock on 5 days since Nov 2016

Nachum “Homi” Shamir is a corporate executive and board director in the medical device and diagnostics industry who has served as an independent director of IsoPlexis Corp. (Nasdaq: ISO), where he was appointed to the Board of Directors as a Class II director and participated on the Compensation and Nominating and Governance Committees.( At IsoPlexis, his role as director drew on decades of experience leading high-growth, publicly traded healthcare and technology companies.(

Prior to his IsoPlexis board service, Shamir was Chairman and Chief Executive Officer of Luminex Corporation from 2014 until its sale to DiaSorin S.p.A. in 2021, and President and Chief Executive Officer of Given Imaging from 2006 until its sale to Covidien (now part of Medtronic) in 2014.( Earlier in his career he led Scitex Digital Printing through its sale to Kodak, and over the last two decades he has managed three successful NASDAQ-listed public companies.( Shamir currently serves on the Board of Directors of Strata Skin Sciences and as Chairman of MediWound Ltd. and Cactus Acquisition Corp., among other board and chair roles in diagnostics and medical technology enterprises, reflecting his specialization in scaling global commercial operations and executing strategic mergers and acquisitions.( (Education details are not publicly disclosed in the cited sources.)

Written by Perplexity from public sources.